Navigation Links
Study findings show value of dietary supplement SAMe in treatment of adults with major depressive disorders
Date:8/31/2010

chool, director of treatment-resistant depression studies in the Department of Psychiatry at MGH, lead author of the current study. "These findings provide preliminary support for the efficacy, safety, and tolerability of SAMe as an additive therapy for patients with major depressive disorders who do not respond to antidepressant treatment alone. Continued research, however, is urgently needed to more definitively further our understanding of the role of SAMe in the treatment of adults diagnosed with depression. Adjunctive SAMe therapy is promising, but cannot yet be recommended for wide-spread clinical use," said Papakostas.

The National Institute of Mental Health funded the study. Pharmavite LLC, the manufacturer of Nature Made SAM-e Complete and the leading distributor of SAMe supplements in the United States, provided the SAMe supplements and placebo pills used in the study.

To date, at least 40 clinical trials have been conducted on SAMe directly and in combination with traditional antidepressant medications. Studies have evaluated SAMe's use in naturally restoring a healthy mood to the most recent research for treating major depressive disorders. This current study follows a pilot study published in 2004 in the Journal of Clinical Psychopharmacology, which concluded that antidepressants used in combination with SAMe were significantly more effective in relieving depression than medication alone.

In an accompanying editorial, J. Craig Nelson, M.D., professor of psychiatry at the University California, San Francisco, wrote, "The study of Papakostas, et al. is persuasive. It is the first adjunctive treatment trial of SAMe and the first placebo-controlled trial of oral SAMe since 1993. The era of development for new amine reuptake inhibitors appears to be coming to a close. Some novel approaches appear to be dead ends. SAMe offers a novel mechanism of treatment action and opens up a new area for future exploration. Of course t
'/>"/>

Contact: Kelsey Hammonds
Kelsey.Hammonds@porternovelli.com
212-601-8285
Porter Novelli
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Despite Treatment, Employees with Depression Generate Higher Absentee Costs, According to Thomson Reuters Study
2. American Council on Exercise (ACE) Study Reveals Kettlebells Provide Powerful Workout in Short Amount of Time
3. TV drama can be more persuasive than news program, study finds
4. Study carried out into biological risks of eating reptiles
5. Neuroimaging study may pave way for effective Alzheimers treatments
6. Study finds racial gaps continue in heart disease awareness
7. Luth Researchs IndicatorEDG(TM) Study Finds Americans Hopes of Achieving Their Dreams Are Fading
8. First blinded study of venous insufficiency prevalence in MS shows promising results
9. Soothing infants with food focus of childhood obesity study
10. People with anxiety disorder less able to regulate response to negative emotions, study shows
11. American Heart Association Rapid Access Journal Report: Study Finds Racial Gaps Continue in Heart Disease Awareness, Low Knowledge of Heart Attack Warning Signs Among Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/5/2015)... ... 05, 2015 , ... Employee Fiduciary has announced the launch ... Financial is a registered investment advisor, serving 401k and other types of retirement ... values and services , providing low-cost, fiduciary–grade investment advice to its clients. ...
(Date:8/5/2015)... ... ... opening of Chicago’s new elevated trail, the 606, has been getting a lot of press ... at Sedgebrook senior living community in Lincolnshire. Known as the Trailblazers, these robust hikers ... month to more distant places. When they read about the 606 on Chicago’s Northwest ...
(Date:8/5/2015)... (PRWEB) , ... August 05, 2015 , ... Stelari introduces ... is reinventing yoga wear with their new line, The Earth’s Song. Combining fashion and ... and into your workout. Inspired by the Australian Outback, this collection is sure to ...
(Date:8/5/2015)... , ... August 05, 2015 , ... ... research funding, as well as awareness, education and support in order to reduce ... Aneurysm Foundation proudly announces this year it has awarded the most funding ...
(Date:8/4/2015)... ... August 05, 2015 , ... MONTICELLO, Fla. – After ... and the Tallahassee Memorial Hospital, this journey as a clinician allowed Dr. Barbara ... This journey equipped her to care for patients, families, friends and staff, and she ...
Breaking Medicine News(10 mins):Health News:Employee Fiduciary Announces Subsidiary 2Health News:Sedgebrook Trailblazers Tread New Ground on Chicago’s New 606 Path 2Health News:Sedgebrook Trailblazers Tread New Ground on Chicago’s New 606 Path 3Health News:Stelari: Bohemian Chic Activewear Line 2Health News:Stelari: Bohemian Chic Activewear Line 3Health News:Brain Aneurysm Foundation Awards Largest Amount of Research Funding at 9th Annual Brain Aneurysm Foundation Research Grant Awards Symposium Sept 10th in Houston, Texas 2Health News:Brain Aneurysm Foundation Awards Largest Amount of Research Funding at 9th Annual Brain Aneurysm Foundation Research Grant Awards Symposium Sept 10th in Houston, Texas 3Health News:Brain Aneurysm Foundation Awards Largest Amount of Research Funding at 9th Annual Brain Aneurysm Foundation Research Grant Awards Symposium Sept 10th in Houston, Texas 4Health News:New book shows how ‘The Presence of a Chaplain’ affects lives 2Health News:New book shows how ‘The Presence of a Chaplain’ affects lives 3
... of the women in a national survey say that ... many of them arent sure if its safe. Yet ... oral contraceptive therapy to suppress menstruation is, in fact, ... by Kurt Barnhart MD, MSCE from the University of ...
... WASHINGTON, Oct. 3 The United States,Conference of ... H.,Palmer, today expressed shock and disbelief at President Bush,s ... Insurance Program known as,SCHIP. With his action, 10 million ... protection., "We are extremely disappointed because this is ...
... 3 The Executives, a support group,of nearly 500 ... to support the Los Angeles Jewish Home, has announced,noted ... the latest,speaker in the organization,s continuing breakfast programs featuring,high-profile ... to,Expect from the 5-4 Supreme Court." The gathering ...
... FACEP (E) Executive,Director American Public Health Association, ... from Georges C. Benjamin, MD, FACP, FACEP (E), ... deeply troubled that, despite overwhelming support from the,general ... Bush,today vetoed the Children,s Health Insurance Program (CHIP), ...
... parents who, while navigating a jam-packed childhood vaccine schedule, can ... pokes by his or her six-month checkup. , The ... no efficacy or safety is compromised when clinicians administer a ... tripling up three of the recommended shots to reduce the ...
... Yawei Ni, DelSite,s CSO, Will Detail Antigen ... of GelSite(R) Polymer, IRVING, Texas, Oct. 3 ... that Dr. Yawei Ni,Chief Scientific Officer of DelSite ... presentation titled "An Effective,Adjuvant Based on a Novel ...
Cached Medicine News:Health News:Differing attitudes found between women and doctors concerning menstrual suppression 2Health News:Mayors Express Frustration Over President Bush's Veto to SCHIP Legislation 2Health News:Los Angeles Jewish Home Support Group Continues High-Profile Speaker Program With Noted Legal Scholar and Expert Laurie L. Levenson 2Health News:APHA Deeply Troubled by Bush Veto of CHIP 2Health News:Combination vaccines okay for infants, study shows 2Health News:Combination vaccines okay for infants, study shows 3Health News:Carrington Subsidiary DelSite to Present at International Vaccine Conference in Ireland 2Health News:Carrington Subsidiary DelSite to Present at International Vaccine Conference in Ireland 3
(Date:8/5/2015)...  Butterfly Network was awarded today as one ... for 2015.  The company is democratizing medical imaging ... By integrating its novel imaging platform with deep ... virtuous cycle, learning as they image, and continually ... chosen by a professional jury among hundreds of ...
(Date:8/4/2015)... and SOUTHAMPTON , ... company Pharmaxis Ltd (ASX: PXS) and UK biotechnology company Synairgen ... research collaboration to develop a selective inhibitor to the lysyl ... disease idiopathic pulmonary fibrosis (IPF). IPF affects ... products are expected to produce global revenues in excess of ...
(Date:8/4/2015)... , Aug. 4, 2015  Eli Lilly and ... of California, San Diego (UCSD) of its intent to ... of the Anti-amyloid Treatment in Asymptomatic Alzheimer,s disease (A4) ... testing solanezumab in the preclinical stage of Alzheimer,s disease ... their brains on a PET scan, but do not ...
Breaking Medicine Technology:Butterfly Network Recognized as a Technology Pioneer by the World Economic Forum 2Pharmaxis and Synairgen Announce Research Collaboration to Develop LOXL2 Inhibitor For Pulmonary Fibrosis 2Pharmaxis and Synairgen Announce Research Collaboration to Develop LOXL2 Inhibitor For Pulmonary Fibrosis 3Lilly to End Contract with the University of California, San Diego for A4 Alzheimer's Study 2Lilly to End Contract with the University of California, San Diego for A4 Alzheimer's Study 3
... PXS; Nasdaq: PXSL) today announced that the company ... reached agreement on the phase 3,registration trial of ... The SPA process allows for FDA evaluation ... primary basis of an efficacy claim in support ...
... 19 The Australian company Fermiscan,who is using ... new breast cancer,screening test through the analysis of ... 69% in detecting breast cancer., (Photo: ... the Journal of the American Medical,Association(1) (US study), ...
Cached Medicine Technology:Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial 2Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial 3New Australian Technology: Detecting Breast Cancer With Hair 2New Australian Technology: Detecting Breast Cancer With Hair 3New Australian Technology: Detecting Breast Cancer With Hair 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: